Table 2.
Clinical characteristics of B-Cell ALL patients (n=14).
| Leukemia diagnosis | Age (yrs) | Sex | WBC count (109/l) | Blast percentage in bone marrow (%) | Syncytin-1 mRNA expression (syncytin-1/GAPDH, means ±SD) |
|---|---|---|---|---|---|
| B-cell ALL | 12 | M | 5.5 | 9.5 | 9.3±0.2 |
| B-cell ALL | 22 | F | 2.16 | 98.5 | 0.5±0.3 |
| B-cell ALL | 67 | M | 5.75 | 74 | 4±1.9 |
| B-cell ALL | 22 | M | 9.73 | 68.5 | 3.7±0.4 |
| B-cell ALL | 23 | M | 4.8 | 92.5 | 19.1±8.1 |
| B-cell ALL | 18 | M | 2.36 | 75 | 10±2.8 |
| B-cell ALL | 6 | F | 4.38 | 84.5 | 11.2±0.8 |
| B-cell ALL | 17 | F | 4.5 | 0.41 | 0.17±0.1 |
| B-cell ALL | 50 | M | 42.7 | 96 | 0.32±0.2 |
| B-cell ALL | 25 | M | 4.54 | 83.5 | 0.99±0.4 |
| CML→B-cell ALL | 46 | M | 51.5 | 89.5 | 1.2±0.5 |
| CML→B-cell ALL | 39 | F | 16.8 | 80.5 | 3.7±0.5 |
| CML→B-cell ALL | 41 | M | 13 | 74.5 | 3.1±0.6 |
| CML→B-cell ALL | 46 | F | 293.7 | 67.8 | 21.4±9.2 |